Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD
Authors Tödt K, Skargren E, Kentson M, Theander K, Jakobsson P, Unosson M
Received 5 August 2013
Accepted for publication 25 September 2013
Published 16 December 2013 Volume 2014:9(1) Pages 17—25
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Kristina Tödt,1,2 Elisabeth Skargren,3 Magnus Kentson,4 Kersti Theander,5,6 Per Jakobsson,2 Mitra Unosson1
1Department of Social and Welfare Studies, Faculty of Health Sciences, Linköping University, Norrköping, Sweden; 2Department of Pulmonary Medicine, University Hospital, 3Department of Medicine and Health, Faculty of Health Sciences, Linköping University, Linköping, Sweden; 4Department of Pulmonary Medicine, Ryhov Hospital, Jönköping, Sweden; 5Department of Nursing, Faculty of Social and Life Sciences, Karlstad University, Karlstad, Sweden; 6Primary Care Research Unit, County Council of Värmland, Sweden
Introduction: Several differences have been reported in the clinical characteristics of chronic obstructive pulmonary disease (COPD) between men and women. Differences have been found in the association between respiratory symptoms and lung function, and in the factors associated with dyspnea. This raises the question of whether there are differences between the sexes in the relationship between fatigue, the second most prevalent symptom, and the variables of physical capacity and disease severity.
Objectives: To examine the experience of fatigue and its relationship to physical capacity and disease severity in men and women with COPD.
Methods: In a cross-sectional study 121 patients with COPD (54 men and 67 women), the experience of fatigue (frequency, duration, and severity) and physical capacity (lung function, 6-minute walk distance [6MWD], grip strength, and timed-stand test) were assessed. Disease severity was graded according to the Body mass index, airway Obstruction, Dyspnoea and Exercise capacity (BODE) index. Two multiple logistic regression models were tested, both of which were performed separately in men and women, to examine the association between the experience of fatigue and variables of physical capacity and the BODE index.
Results: Eighty-nine (73.6%) patients experienced fatigue, with similar proportions in men and women. The men with fatigue had worse physical capacity and more severe disease than did the men without fatigue: for men with and without fatigue, respectively, the percent of predicted forced expiratory volume in 1 second (FEV1) (mean [standard deviation]) was 47 (14) vs 64 (17); the 6MWD (mean [standard deviation]) was 398 (138) vs 539 (105) m; and the BODE index (median [quartile 1-3]) was 3 (2–5) vs 1 (0–1) (P<0.01). In women, only higher leg fatigue post-6MWD was seen among those experiencing fatigue compared with women without fatigue: for women with and without fatigue, respectively, leg fatigue (median [quartile 1-3]) was 4 (3–5) vs 2 (0–3) (P<0.001). The regression models showed that the 6MWD and the BODE index were associated with fatigue in both men and women, but in women, leg fatigue remained an independent associate in both models.
Conclusion: Exercise capacity and disease severity were associated with fatigue in both men and women. In women, leg fatigue was strongly associated with fatigue, which warrants further investigation.
Keywords: chronic obstructive pulmonary disease, disease state, functional capacity, sex differences, symptom experience, leg fatigue
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Readers of this article also read:
Novotna B, Koblizek V, Zatloukal J, Plutinsky M, Hejduk K, Zbozinkova Z, Jarkovsky J, Sobotik O, Dvorak T, Safranek P
Published Date: 10 November 2014
Smith MC, Wrobel JP
Published Date: 27 August 2014
Evaluation of ghrelin level and appetite regulation in patients with acute exacerbations of chronic obstructive pulmonary disease
Wang Y, Shen Y, Zuo Q, Zhao L, Wan C, Tian P, Chen L, Wen F
Published Date: 14 August 2014
Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis
Blakemore A, Dickens C, Guthrie E, Bower P, Kontopantelis E, Afzal C, Coventry PA
Published Date: 20 May 2014
Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients?
Hassan HA, Aziz NA, Hassan Y, Hassan F
Published Date: 14 May 2014
Caramori G, Adcock IM, Di Stefano A, Chung KF
Published Date: 28 April 2014
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID
Published Date: 7 February 2014
Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences
Ohno T, Wada S, Hanada S, Sawaguchi H, Muraki M, Tohda Y
Published Date: 21 January 2014
Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease
Nath KD, Burel JG, Shankar V, Pritchard AL, Towers M, Looke D, Davies JM, Upham JW
Published Date: 24 December 2013
Effect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial
Kikuchi H, Shiozawa N, Takata S, Ashida K, Mitsunobu F
Published Date: 12 December 2013